Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas

Journal of Biological Chemistry

Volumn 287, Issue 45, 2012, Pages 37917-37925

  Brock, Stephanie E ^a   Rendon, Beatriz E ^a   Yaddanapudi, Kavitha ^a   Mitchell, Robert A ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA CELLS; AMP-ACTIVATED PROTEIN KINASE; LUNG CANCER; MIGRATION INHIBITORY FACTORS;

CELL CULTURE; MACROPHAGES;

BIOLOGICAL ORGANS;

ADENOSINE TRIPHOSPHATE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CD74 ANTIGEN; CELL SURFACE RECEPTOR; DOPACHROME TAUTOMERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIVER KINASE B1; MACROPHAGE MIGRATION INHIBITION FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG NON SMALL CELL CANCER; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; STEADY STATE;

ACETYLCYSTEINE; AMP-ACTIVATED PROTEIN KINASES; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DEOXYGLUCOSE; ENZYME ACTIVATION; FREE RADICAL SCAVENGERS; GLUCOSE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOBLOTTING; INTRAMOLECULAR OXIDOREDUCTASES; LUNG NEOPLASMS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MUTATION; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84868330127     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.378299     Document Type: Article

References (47)

1. Hardie, D. G. (2007) AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 8, 774-7855
2. Luo, Z., Zang, M., and Guo, W. (2010) AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol. 6, 457-4700
3. Makowski, L., and Hayes, D. N. (2008)Role of LKB1 in lung cancer development. Br. J. Cancer 99, 683-6888
4. Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., Liang, M. C., Cai, D., Naumov, G. N., Bao, L., Contreras, C. M., Li, D., Chen, L., Krishnamurthy, J., Koivunen, J., Chirieac, L. R., Padera, R. F., Bronson, R. T., Lindeman, N. I., Christiani, D. C., Lin, X., Shapiro, G. I., Jänne, P. A., Johnson, B. E., Meyerson, M., Kwiatkowski, D. J., Castrillon, D. H., Bardeesy, N., Sharpless, N. E., and Wong, K. K. (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448, 807-8100
5. Bacher, M., Schrader, J., Thompson, N., Kuschela, K., Gemsa, D., Waeber, G., and Schlegel, J. (2003) Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am. J. Pathol. 162, 11-177
6. Winner, M., Koong, A. C., Rendon, B. E., Zundel, W., and Mitchell, R. A. (2007) Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. Cancer Res. 67, 186-1933
7. McClelland, M., Zhao, L., Carskadon, S., and Arenberg, D. (2009)Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am. J. Pathol. 174, 638-6466
8. White, E. S., Flaherty, K. R., Carskadon, S., Brant, A., Iannettoni, M. D., Yee, J., Orringer, M. B., and Arenberg, D. A. (2003) Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin. Cancer Res. 9, 853-8600
9. Rendon, B. E., Roger, T., Teneng, I., Zhao, M., Al-Abed, Y., Calandra, T., and Mitchell, R. A. (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J. Biol. Chem. 282, 29910-299188
10. Winner, M., Meier, J., Zierow, S., Rendon, B. E., Crichlow, G. V., Riggs, R., Bucala, R., Leng, L., Smith, N., Lolis, E., Trent, J. O., and Mitchell, R. A. (2008)A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Cancer Res. 68, 7253-72577
11. Coleman, A. M., Rendon, B. E., Zhao, M., Qian, M. W., Bucala, R., Xin, D., and Mitchell, R. A. (2008)Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase. J. Immunol. 181, 2330-23377
12. Welford, S. M., Bedogni, B., Gradin, K., Poellinger, L., Broome Powell, M., and Giaccia, A. J. (2006) HIF1-delays premature senescence through the activation of MIF. Genes Dev. 20, 3366-33711
13. Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., and Beach, D. H. (1999)A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190, 1375-13822
14. Fingerle-Rowson, G., Petrenko, O., Metz, C. N., Forsthuber, T. G., Mitchell, R., Huss, R., Moll, U., Müller, W., and Bucala, R. (2003) The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc. Natl. Acad. Sci. U.S.A. 100, 9354-93599
15. Martin, J., Duncan, F. J., Keiser, T., Shin, S., Kusewitt, D. F., Oberyszyn, T., Satoskar, A. R., and VanBuskirk, A. M. (2009)Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB)-induced nonmelanoma skin cancer (NMSC). FASEB J. 23, 720-7300
16. Miller, E. J., Li, J., Leng, L., McDonald, C., Atsumi, T., Bucala, R., and Young, L. H. (2008)Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 451, 578-5822
17. Heinrichs, D., Knauel, M., Offermanns, C., Berres, M. L., Nellen, A., Leng, L., Schmitz, P., Bucala, R., Trautwein, C., Weber, C., Bernhagen, J., and Wasmuth, H. E. (2011) Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc. Natl. Acad. Sci. U.S.A. 108, 17444-174499
18. Iwata, T., Taniguchi, H., Kuwajima, M., Taniguchi, T., Okuda, Y., Sukeno, A., Ishimoto, K., Mizusawa, N., and Yoshimoto, K. (2012) The action of D-dopachrome tautomerase as an adipokine in adipocyte lipid metabolism. PLoS ONE 7, e334022
19. Rocha, G. Z., Dias, M. M., Ropelle, E. R., Osório-Costa, F., Rossato, F. A., Vercesi, A. E., Saad, M. J., and Carvalheira, J. B. (2011) Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth. Clin. Cancer Res. 17, 3993-40055
20. Swinnen, J. V., Beckers, A., Brusselmans, K., Organe, S., Segers, J., Timmermans, L., Vanderhoydonc, F., Deboel, L., Derua, R., Waelkens, E., De Schrijver, E., Van de Sande, T., Noël, A., Foufelle, F., and Verhoeven, G. (2005) Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype. Cancer Res. 65, 2441-24488
21. Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., and Cantley, L. C. (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A. 101, 3329-33355
22. Sim, A. T., and Hardie, D. G. (1988) The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Lett. 233, 294-2988
23. Marsh, B. J., Alm, R. A., McIntosh, S. R., and James, D. E. (1995) Molecular regulation of GLUT4 targeting in 3T3-L1 adipocytes. J. Cell Biol. 130, 1081-10911
24. Tarnowski, M., Grymula, K., Liu, R., Tarnowska, J., Drukala, J., Ratajczak, J., Mitchell, R. A., Ratajczak, M. Z., and Kucia, M. (2010) Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors, and inhibits recruitment of cancer-associated fibroblasts. Mol. Cancer Res. 8, 1328-13433
25. Munday, M. R., Campbell, D. G., Carling, D., and Hardie, D. G. (1988) Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur. J. Biochem. 175, 331-3388
26. Merk, M., Mitchell, R. A., Endres, S., and Bucala, R. (2012) D-Dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family. Cytokine 59, 10-177
27. Inoki, K., Zhu, T., and Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-5900
28. Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., De-Pinho, R. A., and Cantley, L. C. (2004) The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6, 91-999
29. Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., and Sabatini, D. M. (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. U.S.A. 95, 1432-14377
30. Liu, L., Cash, T. P., Jones, R. G., Keith, B., Thompson, C. B., and Simon, M. C. (2006) Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol. Cell 21, 521-5311
31. Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., and Thompson, C. B. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283-2933
32. Woods, A., Azzout-Marniche, D., Foretz, M., Stein, S. C., Lemarchand, P., Ferré, P., Foufelle, F., and Carling, D. (2000) Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell. Biol. 20, 6704-67111
33. Oakhill, J. S., Steel, R., Chen, Z. P., Scott, J. W., Ling, N., Tam, S., and Kemp, B. E. (2011) AMPK is a direct adenylate charge-regulated protein kinase. Science 332, 1433-14355
34. Benigni, F., Atsumi, T., Calandra, T., Metz, C., Echtenacher, B., Peng, T., and Bucala, R. (2000) The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J. Clin. Invest. 106, 1291-13000
35. Waeber, G., Calandra, T., Roduit, R., Haefliger, J. A., Bonny, C., Thompson, N., Thorens, B., Temler, E., Meinhardt, A., Bacher, M., Metz, C. N., Nicod, P., and Bucala, R. (1997) Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. U.S.A. 94, 4782-47877
36. Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., and Brugge, J. S. (2009)Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461, 109-1133
37. Carretero, J., Medina, P. P., Pio, R., Montuenga, L. M., and Sanchez-Cespedes, M. (2004) Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene 23, 4037-40400
38. Matsumoto, S., Iwakawa, R., Takahashi, K., Kohno, T., Nakanishi, Y., Matsuno, Y., Suzuki, K., Nakamoto, M., Shimizu, E., Minna, J. D., and Yokota, J. (2007) Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26, 5911-59188
39. Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., and Hardie, D. G. (2005) Calmodulin-dependent protein kinase kinase-is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9-199
40. Gusarova, G. A., Trejo, H. E., Dada, L. A., Briva, A., Welch, L. C., Hamanaka, R. B., Mutlu, G. M., Chandel, N. S., Prakriya, M., and Sznajder, J. I. (2011) Hypoxia leads to Na, K-ATPase down-regulation via Ca2+ releaseactivated Ca2+ channels and AMPK activation. Mol. Cell Biol. 31, 3546-35566
41. Mungai, P. T., Waypa, G. B., Jairaman, A., Prakriya, M., Dokic, D., Ball, M. K., and Schumacker, P. T. (2011) Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium releaseactivated calcium channels. Mol. Cell. Biol. 31, 3531-35455
42. Ballatori, N., Krance, S. M., Notenboom, S., Shi, S., Tieu, K., and Hammond, C. L. (2009)Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 390, 191-2144
43. Wang, H., and Joseph, J. A. (1999)Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27, 612-6166
44. Xin, D., Rendon, B. E., Zhao, M., Winner, M., McGhee Coleman, A., and Mitchell, R. A. (2010) The MIF homolog, D-dopachrome tautomerase (D-DT), promotes COX-2 expression through-catenin-dependent and independent mechanisms. Mol. Cancer Res. 8, 1601-16099
45. Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R., and Kaelin, W. G., Jr. (2003) TSC2 regulates VEGF through mTOR-dependent and-independent pathways. Cancer Cell 4, 147-1588
46. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., Kooistra, T., Fingerle-Rowson, G., Ghezzi, P., Kleemann, R., McColl, S. R., Bucala, R., Hickey, M. J., and Weber, C. (2007) MIF is a noncognate ligand ofCXCchemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-5966
47. Weber, C., Kraemer, S., Drechsler, M., Lue, H., Koenen, R. R., Kapurniotu, A., Zernecke, A., and Bernhagen, J. (2008)Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment. Proc. Natl. Acad. Sci. U.S.A. 105, 16278-162833